Activity ratios measure how efficiently a company performs day-to-day tasks, such us the collection of receivables and management of inventory.
Paying user area
Try for free
Medtronic PLC pages available for free this week:
- Statement of Comprehensive Income
- Analysis of Reportable Segments
- Enterprise Value to FCFF (EV/FCFF)
- Selected Financial Data since 2005
- Net Profit Margin since 2005
- Current Ratio since 2005
- Debt to Equity since 2005
- Total Asset Turnover since 2005
- Price to Book Value (P/BV) since 2005
- Aggregate Accruals
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Medtronic PLC for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Long-term Activity Ratios (Summary)
Based on: 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26).
Long-term activity ratio | Description | The company |
---|---|---|
Net fixed asset turnover | An activity ratio calculated as total revenue divided by net fixed assets. | Medtronic PLC net fixed asset turnover ratio deteriorated from 2022 to 2023 and from 2023 to 2024. |
Net fixed asset turnover (including operating lease, right-of-use asset) | An activity ratio calculated as total revenue divided by net fixed assets (including operating lease, right-of-use asset). | Medtronic PLC net fixed asset turnover ratio (with operating lease, right-of-use asset) deteriorated from 2022 to 2023 and from 2023 to 2024. |
Total asset turnover | An activity ratio calculated as total revenue divided by total assets. | Medtronic PLC total asset turnover ratio deteriorated from 2022 to 2023 but then improved from 2023 to 2024 exceeding 2022 level. |
Equity turnover | An activity ratio calculated as total revenue divided by shareholders’ equity. | Medtronic PLC equity turnover ratio improved from 2022 to 2023 and from 2023 to 2024. |
Net Fixed Asset Turnover
Apr 26, 2024 | Apr 28, 2023 | Apr 29, 2022 | Apr 30, 2021 | Apr 24, 2020 | Apr 26, 2019 | ||
---|---|---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | |||||||
Net sales | |||||||
Property, plant, and equipment, net | |||||||
Long-term Activity Ratio | |||||||
Net fixed asset turnover1 | |||||||
Benchmarks | |||||||
Net Fixed Asset Turnover, Competitors2 | |||||||
Abbott Laboratories | |||||||
Cigna Group | |||||||
CVS Health Corp. | |||||||
Elevance Health Inc. | |||||||
Humana Inc. | |||||||
Intuitive Surgical Inc. | |||||||
UnitedHealth Group Inc. | |||||||
Net Fixed Asset Turnover, Sector | |||||||
Health Care Equipment & Services | |||||||
Net Fixed Asset Turnover, Industry | |||||||
Health Care |
Based on: 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26).
1 2024 Calculation
Net fixed asset turnover = Net sales ÷ Property, plant, and equipment, net
= ÷ =
2 Click competitor name to see calculations.
Long-term activity ratio | Description | The company |
---|---|---|
Net fixed asset turnover | An activity ratio calculated as total revenue divided by net fixed assets. | Medtronic PLC net fixed asset turnover ratio deteriorated from 2022 to 2023 and from 2023 to 2024. |
Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset)
Medtronic PLC, net fixed asset turnover (including operating lease, right-of-use asset) calculation, comparison to benchmarks
Apr 26, 2024 | Apr 28, 2023 | Apr 29, 2022 | Apr 30, 2021 | Apr 24, 2020 | Apr 26, 2019 | ||
---|---|---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | |||||||
Net sales | |||||||
Property, plant, and equipment, net | |||||||
Operating lease right-of-use assets (classified in Other assets) | |||||||
Property, plant, and equipment, net (including operating lease, right-of-use asset) | |||||||
Long-term Activity Ratio | |||||||
Net fixed asset turnover (including operating lease, right-of-use asset)1 | |||||||
Benchmarks | |||||||
Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset), Competitors2 | |||||||
Abbott Laboratories | |||||||
Cigna Group | |||||||
CVS Health Corp. | |||||||
Elevance Health Inc. | |||||||
Humana Inc. | |||||||
Intuitive Surgical Inc. | |||||||
UnitedHealth Group Inc. | |||||||
Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset), Sector | |||||||
Health Care Equipment & Services | |||||||
Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset), Industry | |||||||
Health Care |
Based on: 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26).
1 2024 Calculation
Net fixed asset turnover (including operating lease, right-of-use asset) = Net sales ÷ Property, plant, and equipment, net (including operating lease, right-of-use asset)
= ÷ =
2 Click competitor name to see calculations.
Long-term activity ratio | Description | The company |
---|---|---|
Net fixed asset turnover (including operating lease, right-of-use asset) | An activity ratio calculated as total revenue divided by net fixed assets (including operating lease, right-of-use asset). | Medtronic PLC net fixed asset turnover ratio (with operating lease, right-of-use asset) deteriorated from 2022 to 2023 and from 2023 to 2024. |
Total Asset Turnover
Apr 26, 2024 | Apr 28, 2023 | Apr 29, 2022 | Apr 30, 2021 | Apr 24, 2020 | Apr 26, 2019 | ||
---|---|---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | |||||||
Net sales | |||||||
Total assets | |||||||
Long-term Activity Ratio | |||||||
Total asset turnover1 | |||||||
Benchmarks | |||||||
Total Asset Turnover, Competitors2 | |||||||
Abbott Laboratories | |||||||
Cigna Group | |||||||
CVS Health Corp. | |||||||
Elevance Health Inc. | |||||||
Humana Inc. | |||||||
Intuitive Surgical Inc. | |||||||
UnitedHealth Group Inc. | |||||||
Total Asset Turnover, Sector | |||||||
Health Care Equipment & Services | |||||||
Total Asset Turnover, Industry | |||||||
Health Care |
Based on: 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26).
1 2024 Calculation
Total asset turnover = Net sales ÷ Total assets
= ÷ =
2 Click competitor name to see calculations.
Long-term activity ratio | Description | The company |
---|---|---|
Total asset turnover | An activity ratio calculated as total revenue divided by total assets. | Medtronic PLC total asset turnover ratio deteriorated from 2022 to 2023 but then improved from 2023 to 2024 exceeding 2022 level. |
Equity Turnover
Apr 26, 2024 | Apr 28, 2023 | Apr 29, 2022 | Apr 30, 2021 | Apr 24, 2020 | Apr 26, 2019 | ||
---|---|---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | |||||||
Net sales | |||||||
Shareholders’ equity | |||||||
Long-term Activity Ratio | |||||||
Equity turnover1 | |||||||
Benchmarks | |||||||
Equity Turnover, Competitors2 | |||||||
Abbott Laboratories | |||||||
Cigna Group | |||||||
CVS Health Corp. | |||||||
Elevance Health Inc. | |||||||
Humana Inc. | |||||||
Intuitive Surgical Inc. | |||||||
UnitedHealth Group Inc. | |||||||
Equity Turnover, Sector | |||||||
Health Care Equipment & Services | |||||||
Equity Turnover, Industry | |||||||
Health Care |
Based on: 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26).
1 2024 Calculation
Equity turnover = Net sales ÷ Shareholders’ equity
= ÷ =
2 Click competitor name to see calculations.
Long-term activity ratio | Description | The company |
---|---|---|
Equity turnover | An activity ratio calculated as total revenue divided by shareholders’ equity. | Medtronic PLC equity turnover ratio improved from 2022 to 2023 and from 2023 to 2024. |